Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MITAPIVAT vs MOBOCERTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MITAPIVAT vs MOBOCERTINIB: Safety Overview

Metric MITAPIVAT MOBOCERTINIB
Total FAERS Reports 627 715
Deaths Reported 4 320
Death Rate 0.6% 44.8%
Hospitalizations 58 227
Average Patient Age 46.6 yrs 65.7 yrs
% Female Patients 53.5% 66.1%
FDA Approval Date Dec 23, 2025 Sep 15, 2021
Manufacturer Agios Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued